Birkenstock beats fourth-quarter revenue estimates-February 2024-www.financetom.com

Birkenstock beats fourth-quarter revenue estimates

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Birkenstock beats fourth-quarter revenue estimates

Dec 18, 2024 2:25 AM

Dec 18 (Reuters) - Birkenstock ( BIRK ) beat market

expectations for fourth-quarter revenue on Wednesday, helped by

robust full-price sales of the German footwear maker's pricey

sandals.

The company reported fourth-quarter revenue of 455.8 million

euros ($478.27 million), compared with the average analyst

estimate of 439.2 million euros, according to data compiled by

LSEG.

($1 = 0.9530 euros)

Previous page： InnoCan Pharma Plans One-for-65 Share Consolidation Ahead of Nasdaq Listing Next page： Avidity Biosciences Insider Sold Shares Worth $1,234,700, According to a Recent SEC Filing

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

InnoCan Pharma Plans One-for-65 Share Consolidation Ahead of Nasdaq Listing

Aug 29, 2025

04:36 PM EDT, 08/29/2025 (MT Newswires) -- InnoCan Pharma ( INNPF ) on Friday said it will consolidate its shares on a one-for-65 basis ahead of a U.S. public offering of shares units and a listing on the Nasdaq Exchange. The company did not say when the consolidation or public offering will be completed. It expects its shares to trade...

Avidity Biosciences Insider Sold Shares Worth $1,234,700, According to a Recent SEC Filing

Aug 29, 2025

04:31 PM EDT, 08/29/2025 (MT Newswires) -- Sarah Boyce, Director, President and CEO, on August 28, 2025, sold 25,000 shares in Avidity Biosciences ( RNA ) for $1,234,700. Following the Form 4 filing with the SEC, Boyce has control over a total of 305,871 common shares of the company, with 305,871 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1599901/000159990125000168/xslF345X05/wk-form4_1756499311.xml ...

Cvs Health Insider Sold Shares Worth $532,650, According to a Recent SEC Filing

Aug 29, 2025

04:31 PM EDT, 08/29/2025 (MT Newswires) -- Anne A. Finucane, Director, on August 20, 2025, sold 7,500 shares in Cvs Health ( CVS ) for $532,650. Following the Form 4 filing with the SEC, Finucane has control over a total of 22,156 common shares of the company, with 22,156 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/64803/000112760225021034/xslF345X05/form4.xml ...

Intel gets $5.7 billion in accelerated CHIPS Act funds

Aug 29, 2025

Aug 29 (Reuters) - Intel ( INTC ) said on Friday it received $5.70 billion in accelerated CHIPS Act funds after easing terms with the U.S. Commerce Department and issued 274.6 million shares to the U.S. ...